
Oligomerix
Oligomerix is a biotechnology company focused on developing disease-modifying and treatment therapeutics for neurodegenerative diseases
$2.7M Series B+ ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredSep 14, 2006 (20 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $2.7M | — | fundraisingfox.com |
Timeline
- Website created
Companies like Oligomerix
EEndlyz TherapeuticsSeed · Apr 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
PPolku TherapeuticsPre Seed · Sep 2024AAnacalypsis TherapeuticsPre Seed · Sep 2026
AAugustine Therapeutics$85M Series A · Mar 2025
AAtavistik Bio$40M Series B+ · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/oligomerix (get a free API key).